Geneious Prime

Step 1: Import genomic and proteomic datasets into Geneious Prime.

Step 2: Use sequence alignment tools to identify differentially expressed genes.

Step 3: Perform pathway analysis to identify key signaling pathways involved in disease.

Step 4: Prioritize potential drug targets based on their role in disease pathways and druggability.

Step 1: Import patient genomic data into Geneious Prime.

Step 2: Use variant calling tools to identify patient-specific genetic variants.

Step 3: Annotate variants with known drug response associations.

Step 4: Develop personalized treatment strategies based on patient's genetic profile.

Step 1: Collect viral or bacterial sequences from infected individuals.

Step 2: Use sequence alignment tools to compare sequences and identify mutations.

Step 3: Build phylogenetic trees to determine the evolutionary relationships between sequences.

Step 4: Trace the spread of the pathogen based on sequence variations and phylogenetic analysis.

Step 1: Import plant genomic data into Geneious Prime.

Step 2: Use genome-wide association studies (GWAS) to identify genes associated with traits.

Step 3: Use gene editing tools to modify genes and enhance desirable traits.

Step 4: Test the modified plants for improved yield and disease resistance.

Step 1: Import antibody sequence data from NGS or Sanger sequencing.

Step 2: Use sequence annotation tools to identify variable regions and CDRs.

Step 3: Use antibody modeling tools to predict antibody structure and binding affinity.

Step 4: Prioritize antibody candidates based on their predicted binding affinity and specificity.